Knowledge Distillery

In this article the authors constructed a 'tripartite network' (TN) and 'combined gene network' (CGN) and their hub-bottleneck and driver nodes (44…

There are concerns on the safety of SARS-CoV-2 vaccination in patients with a history of Guillain-Barré syndrome (GBS), chronic inflammatory…

Neurological complications have been associated with COVID-19, including delirium. Such complications have been reported to be frequent among ICU…

In humans, several respiratory viruses can have neurologic implications affecting both central and peripheral nervous system.

Clinical outcomes of MS patients affected by Covid-19 have been deeply investigated, but a further analysis on main signs and symptoms and their risk…

Dizziness and vertigo are common post-COVID-19-vaccination symptoms. In this article the authors aimed to prospectively evaluate objective central or…

Different neurological manifestations of COVID-19 in adults and children and their impact have not been well characterized. In this article the…

Increased anxious-depressive symptomatology is observed in the preclinical stage of Alzheimer’s disease (AD), which may accelerate disease…

This study assessed the prevalence of anti-SARS-CoV-2 antibodies in therapeutic immunoglobulin and their impact on serological response to COVID-19…

The patterns of long-term risk of SARS-CoV-2 infection, hospitalization for COVID-19, and related death are uncertain in people with Parkinson disease…

COVID-19 affects the respiratory parenchyma and may potentially contribute to the tendency of myasthenia gravis (MG) patients to develop respiratory…

The coronavirus disease 2019 (COVID-19) vaccination coverage, willingness, and safety profiles in patients with epilepsy remain poorly understood.